A few thoughts about navigating biopharma macro scenarios
- By Phil Berk and Marc Herant
- Biopharma
Planning biopharma strategies against a robust set of macro-scenarios will be crucial to mid- and long-term success. While historically these scenarios have revolved around targeted issues, the current challengescall for a more expansive - and likely more difficult - set of questions to be asked.